MedTrace Logo MedTrace
Clinical Trials News Drugs Diseases Companies About

Xaluritamig

  1. Home
  2. Drugs
  3. Xaluritamig
  4. Clinical Trials

Clinical Trials Related to Xaluritamig

Related studies linked through entity extraction aliases.

NCT07493512

Trial of Xaluritamig in Adults With Metastatic Castration-resistant Prostate Cancer

Status
RECRUITING
Phase
PHASE1

NCT07297979

Evaluation of Xaluritamig in Adults, Adolescents and Children With Relapsed or Refractory Ewing Sarcoma (EWS)

Status
RECRUITING
Phase
PHASE1

NCT07213674

A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer

Status
RECRUITING
Phase
PHASE3

NCT07140900

Study Evaluating the Safety, Tolerability, and Efficacy of Xaluritamig in Combination With Androgen Receptor Pathway Inhibitors in Participants With Metastatic Hormone-sensitive Prostate Cancer

Status
RECRUITING
Phase
PHASE1

NCT06691984

Phase 3 Study of Xaluritamig vs Cabazitaxel or Second Androgen Receptor-Directed Therapy in Participants With Progressive Metastatic Castration-Resistant Prostate Cancer (XALute)

Status
ACTIVE_NOT_RECRUITING
Phase
PHASE3

NCT06613100

Evaluation of Neoadjuvant Xaluritamig in Localized Prostate Cancer

Status
RECRUITING
Phase
PHASE1

NCT06555796

Evaluation of Xaluritamig in High-Risk, Biochemically Recurrent, Non-metastatic Castrate-sensitive Prostate Cancer

Status
ACTIVE_NOT_RECRUITING
Phase
PHASE1

Clinical Trials

Explore studies by the year of their last update.

  • 2026
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • 2008
  • 2007
  • 2006
  • 2005

News & Analysis

Latest news and insights on clinical trials and medical research.

Browse All News →
MedTrace Logo MedTrace
About Privacy Policy Terms of Service Medical Disclaimer

© 2026 MedTrace.
Open-access medical & pharmaceutical data intelligence.